Eduardo Davila

Company: Trampoline Pharma

Job title: Chief Scientific Officer

Seminars:

Roundtable: Aligning Industry & Academic Establishments to Accelerate TIL Discovery 2:30 pm

Increasing access to tissue samples, clinical and real-life data to empower R&D efforts Evaluating key opportunities in partnerships between clinical institutions and industry Discussing hurdles in academia and industry to the spread of data and publishing of results to advance shared knowledge of TILsRead more

day: Conference Day One - Track A - PM

Panel Discussion: Key Considerations for Increasing TIL Treatment Capacity & Preparing for Commercialization 8:30 am

What are key steps to increase TIL infrastructure and meet patient demand? Considerations such as TIL treatment facilities, staff recruitment and training, and resources What are the model regulatory and reimbursement strategies for TILs? Navigating the current regulatory landscape and discussing key considerations when preparing for commercializationRead more

day: Conference Day Two

Lowering TCR & IL2 Receptor Activation Threshold 5:30 pm

Importance of reducing or eliminating IL2 for TIL therapy Mechanisms that lower the activation threshold activation threshold of gamma common chain signaling enhance T-cell persistence while reducing toxicityRead more

day: Conference Day One